News and Trends 10 Nov 2022Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and ALS NRG Therapeutics, Ltd. has closed a £16 million ($18.2 million) series A financing. The funding was led by Omega Funds… November 10, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email